Analyst Price Target is $28.50
▲ +98.74% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Treace Medical Concepts in the last 3 months. The average price target is $28.50, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 98.74% upside from the last price of $14.34.
Current Consensus is
The current consensus among 4 contributing investment analysts is to buy stock in Treace Medical Concepts.
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.